1. Home
  2. MDRR vs CVM Comparison

MDRR vs CVM Comparison

Compare MDRR & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDRR

Medalist Diversified REIT Inc.

BUY

Current Price

$11.16

Market Cap

18.3M

Sector

Real Estate

ML Signal

BUY

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$1.02

Market Cap

21.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDRR
CVM
Founded
2015
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
21.4M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
MDRR
CVM
Price
$11.16
$1.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.8K
337.2K
Earning Date
03-02-2026
05-13-2026
Dividend Yield
2.43%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
65.45
52 Week Low
$9.47
$0.89
52 Week High
$14.52
$13.48

Technical Indicators

Market Signals
Indicator
MDRR
CVM
Relative Strength Index (RSI) 47.94 30.95
Support Level $9.82 $0.94
Resistance Level $12.23 $1.59
Average True Range (ATR) 0.33 0.11
MACD -0.01 0.03
Stochastic Oscillator 27.42 5.24

Price Performance

Historical Comparison
MDRR
CVM

About MDRR Medalist Diversified REIT Inc.

Medalist Diversified Inc owns ten investment properties comprised of three retail properties, three flex/industrial properties, and four STNL properties, including the Tesla Pensacola Property. Through its subsidiary, the company sponsors Delaware Statutory Trusts (DSTs) that provide accredited investors access to institutional-quality real estate with the transparency and governance of a public company. The company has three reportable segments, consisting of retail center properties, flex center properties, and STNL properties. The company generates the majority of its revenue from the Retail Center Property.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: